Lub npe | Semaglutide Txhaj Tshuaj |
Xeev | Lyophilized Hmoov Peptide |
Qhov tshwm sim | Dawb hmoov |
Qib | Qib Kho Mob |
Purity | 99% |
Loj | 10 mg, 15 mg, 20 mg, 30 mg |
Kev tswj hwm | Kev txhaj tshuaj subcutaneous |
Lub zog | 0.25 mg koob, 0.5mg koob koob, 1mg koob koob, 1.7mg koob cwj mem, 2.4mg koob cwj mem, 0.5mg ib koob, 1mg ib koob, 2mg ib koob |
Cov txiaj ntsig | Kho mob ntshav qab zib |
Glucose-dependent Insulin secretion
Semaglutide txhim kho insulin secretion hauv cov piam thaj-dependant, txhais tau tias nws nce insulin tso tawm tsuas yog thaum cov ntshav qab zib nce siab. Qhov no pab txhim kho cov ntshav qab zib kom tsawg thiab txo qhov kev pheej hmoo ntawm hypoglycemia.
Glucagon Inhibition
Glucagon yog ib yam tshuaj uas tsim los ntawm cov txiav ua lub luag haujlwm tseem ceeb hauv kev tswj cov ntshav qab zib los ntawm kev txhawb lub siab kom tso cov piam thaj rau hauv cov ntshav. Los ntawm inhibiting kev tso tawm ntawm glucagon, semaglutide pab txo cov ntshav qab zib hauv cov neeg mob ntshav qab zib. Los ntawm kev txo qis glucagon, semaglutide ntxiv pab tswj cov ntshav qab zib kom noj qab haus huv, uas yog qhov tshwj xeeb tshaj yog rau cov neeg mob ntshav qab zib hom 2.